Oklahoma Perinatal Quality Improvement Collaborative

11/04/2026

Pregnancy and postpartum psychosis (PPP) is a medical emergency impacting 1-2 individuals per 1,000 births.

Untreated, this condition can have devastating impacts on the mother and family.

It is critical for healthcare professionals to understand this condition and learn how to screen for it, treat it, and help the mother reach recovery.

In this webinar, experts will cover:

✅ Statistics, signs, and symptoms
✅ Protocols for treatment and recovery
✅ Lived experience with this condition
✅ Organizations providing resources and raising awareness to support those impacted by PPP

REGISTER TODAY: https://hubs.la/Q04D0GzY0

The presenter line-up includes:

⭐ Julia Alzoubaidi, PhD, PMH-C
Postpartum Psychosis Program Manager, Postpartum Support International

⭐ Nirmaljit Kaur Dhami, MD, DFAPA
Medical Director of Inpatient Perinatal Psychiatry, Scrivner Center for Mental Health & Addiction Services at El Camino Health

⭐ Kristina Dulaney, RN, PMH-C
Founder & Executive Director, Cherished Mom

⭐ Kriti Lodha
Board Member, Postpartum Support International; Board Liaison, Postpartum Psychosis Taskforce

11/02/2026

💜 November is Prematurity Awareness Month

For families, a premature birth can mean an unexpected journey filled with uncertainty, lengthy NICU stays, and difficult decisions.

Babies born too soon face increased risks of breathing difficulties, feeding challenges, infections, and developmental delays. Some may experience long-term health complications that require ongoing medical care, therapies, and additional support.

The impact extends beyond the baby. Families may face emotional stress, financial strain, time away from work, and the challenges of balancing hospital visits with responsibilities at home.

While advances in neonatal care have improved outcomes for premature infants, preventing preterm birth whenever possible remains an important public health priority.

At OPQIC, we're committed to working with Oklahoma's hospitals and healthcare partners to improve maternal and infant health, reduce preventable complications, and support healthier beginnings for Oklahoma families.

Every additional week of pregnancy can make a difference. 💜

11/02/2026

Factors Associated with Nonadherence to American College of Obstetricians and Gynecologists Guidelines for Labor Arrest Disorders https://ow.ly/ZtoV5102T42

11/02/2026

10/31/2026

Learn more about the unbundling of obstetric codes-

Join the Society for Maternal Fetal Medicine Coding Committee Leadership Team for a high-level overview of the current landscape surrounding the unbundling of obstetric global codes.

The panel will review what is currently known, including E/M and discharge codes, and what remains uncertain, followed by an open forum Q&A.

Attendees will have the opportunity to submit questions in real time for the panel to address during the webinar.

📆 November 12, 2026
⏰ 7:30 pm ET

Details:
The recording will be made available after the live session.
This webinar is free to attend.

Speakers:
Barbra Fisher, MD, PhD (Chair),
Katherine Kohari, MD (Vice Chair),
Stephen Bacak, MD (Course Chair),
Trisha Malisch, CCS-P, CPC, COBGC (Lead Coder),
SMFM Coding Committee Leadership Team

REGISTER: https://hubs.la/Q04CMyY70

10/30/2026

OSU Medicine's Maternal and Addiction Recovery Care Program is the first in eastern Oklahoma to bring together board-certified addiction medicine and OB-GYN physicians to deliver integrated pregnancy, addiction treatment and wraparound support.

10/28/2026

10/26/2026

Cardiovascular disease is the leading cause of death in women, accounting for one in three deaths.

To help your health care professionals identify cardiovascular risk and act earlier, ACOG collaborated with the American Heart Association, American Academy of Pediatrics, and the Society for Maternal-Fetal Medicine on a new framework outlining how physicians can support heart health from childhood through adulthood.

The new framework gives ob-gyns and other clinicians the tools they need to understand the connection between heart health, hormones, and mental well-being so they can better tailor screening, prevention, and treatment considerations for heart disease.

Questions about your heart health? Talk with your ob-gyn at any stage and any age.

Read the framework: https://bit.ly/4yB3UTb

10/23/2026

The use of GLP-1s is rising, but data on how these medications affect pregnancy or breastfeeding are still limited.

ACOG’s new guidance recommends that ob-gyns talk with patients about the limited safety data available, and that patients consider stopping GLP-1 medications one to two months before becoming pregnant. Ob-gyns should also share with patients that it’s unclear how GLP-1 medications may affect breastfeeding and discuss the potential benefits and risks.

Talk with your ob-gyn if you have questions about GLP-1 medications and pregnancy.

Read the full press release: https://bit.ly/4dURb6s